ELEVANCE HEALTH INC (A58.DE) Stock Fundamental Analysis
Europe - FRA:A58 - US0367521038 - Common Stock
295.6 EUR
-1.3 (-0.44%)
Overall A58 gets a fundamental rating of 4 out of 10. We evaluated A58 against 27 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of A58 while its profitability can be described as average. A58 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year A58 was profitable.
In the past year A58 had a positive cash flow from operations.
In the past 5 years A58 has always been profitable.
A58 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
A58's Return On Assets of 4.51% is amongst the best of the industry. A58 outperforms 81.48% of its industry peers.
A58 has a Return On Equity of 12.59%. This is in the better half of the industry: A58 outperforms 70.37% of its industry peers.
A58 has a Return On Invested Capital of 5.32%. This is comparable to the rest of the industry: A58 outperforms 59.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for A58 is in line with the industry average of 5.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROIC | 5.32% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
A58 has a Profit Margin of 2.84%. This is comparable to the rest of the industry: A58 outperforms 59.26% of its industry peers.
A58's Profit Margin has declined in the last couple of years.
A58's Operating Margin of 4.35% is in line compared to the rest of the industry. A58 outperforms 48.15% of its industry peers.
A58's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), A58 is destroying value.
Compared to 1 year ago, A58 has less shares outstanding
The number of shares outstanding for A58 has been reduced compared to 5 years ago.
Compared to 1 year ago, A58 has a worse debt to assets ratio.
2.2 Solvency
A58 has a debt to FCF ratio of 8.63. This is a slightly negative value and a sign of low solvency as A58 would need 8.63 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.63, A58 perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
A58 has a Debt/Equity ratio of 0.71. This is a neutral value indicating A58 is somewhat dependend on debt financing.
The Debt to Equity ratio of A58 (0.71) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Altman-Z | N/A |
ROIC/WACC0.62
WACC8.62%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
A58 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
The Earnings Per Share has been growing by 11.17% on average over the past years. This is quite good.
Looking at the last year, A58 shows a quite strong growth in Revenue. The Revenue has grown by 11.96% in the last year.
A58 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%10.95%
3.2 Future
Based on estimates for the next years, A58 will show a small growth in Earnings Per Share. The EPS will grow by 7.89% on average per year.
A58 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.93% yearly.
EPS Next Y-8.41%
EPS Next 2Y-3.9%
EPS Next 3Y1.64%
EPS Next 5Y7.89%
Revenue Next Year12.47%
Revenue Next 2Y8.69%
Revenue Next 3Y7.74%
Revenue Next 5Y7.93%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.21, the valuation of A58 can be described as very reasonable.
Based on the Price/Earnings ratio, A58 is valued cheaper than 88.89% of the companies in the same industry.
A58 is valuated cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
A58 is valuated reasonably with a Price/Forward Earnings ratio of 11.30.
77.78% of the companies in the same industry are more expensive than A58, based on the Price/Forward Earnings ratio.
A58's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.09.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.21 | ||
| Fwd PE | 11.3 |
4.2 Price Multiples
A58's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, A58 is valued a bit more expensive than 62.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.82 | ||
| EV/EBITDA | 10.05 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1
EPS Next 2Y-3.9%
EPS Next 3Y1.64%
5. Dividend
5.1 Amount
A58 has a Yearly Dividend Yield of 1.98%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.53, A58 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.30, A58 has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
5.2 History
On average, the dividend of A58 grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
A58 pays out 27.56% of its income as dividend. This is a sustainable payout ratio.
A58's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-3.9%
EPS Next 3Y1.64%
FRA:A58 (10/24/2025, 7:00:00 PM)
295.6
-1.3 (-0.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap66.56B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts76.43
Price Target318.55 (7.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
Yearly Dividend5.64
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)4
Avg Revenue beat(4)1.62%
Min Revenue beat(4)0.29%
Max Revenue beat(4)4.3%
Revenue beat(8)7
Avg Revenue beat(8)1.16%
Revenue beat(12)9
Avg Revenue beat(12)1.25%
Revenue beat(16)12
Avg Revenue beat(16)1.04%
PT rev (1m)-42.81%
PT rev (3m)-42.81%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-51.39%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-29.11%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)6.39%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)5.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.21 | ||
| Fwd PE | 11.3 | ||
| P/S | 0.4 | ||
| P/FCF | 20.82 | ||
| P/OCF | 15.92 | ||
| P/B | 1.76 | ||
| P/tB | 18.56 | ||
| EV/EBITDA | 10.05 |
EPS(TTM)26.36
EY8.92%
EPS(NY)26.16
Fwd EY8.85%
FCF(TTM)14.2
FCFY4.8%
OCF(TTM)18.56
OCFY6.28%
SpS743.28
BVpS167.69
TBVpS15.93
PEG (NY)N/A
PEG (5Y)1
Graham Number315.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROCE | 6.96% | ||
| ROIC | 5.32% | ||
| ROICexc | 5.73% | ||
| ROICexgc | 9.91% | ||
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A | ||
| FCFM | 1.91% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 74.45% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.59% | ||
| Profit Quality | 67.25% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACC8.62%
ROIC/WACC0.62
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.41%
EPS Next 2Y-3.9%
EPS Next 3Y1.64%
EPS Next 5Y7.89%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%10.95%
Revenue Next Year12.47%
Revenue Next 2Y8.69%
Revenue Next 3Y7.74%
Revenue Next 5Y7.93%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / A58.DE FAQ
Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?
ChartMill assigns a fundamental rating of 4 / 10 to A58.DE.
Can you provide the valuation status for ELEVANCE HEALTH INC?
ChartMill assigns a valuation rating of 4 / 10 to ELEVANCE HEALTH INC (A58.DE). This can be considered as Fairly Valued.
What is the profitability of A58 stock?
ELEVANCE HEALTH INC (A58.DE) has a profitability rating of 4 / 10.
How financially healthy is ELEVANCE HEALTH INC?
The financial health rating of ELEVANCE HEALTH INC (A58.DE) is 2 / 10.
Is the dividend of ELEVANCE HEALTH INC sustainable?
The dividend rating of ELEVANCE HEALTH INC (A58.DE) is 5 / 10 and the dividend payout ratio is 27.56%.